Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Mannatech, Incorporated (MTEX) Stock Forecast & Price Prediction United States | NASDAQ | Consumer Defensive | Food Distribution
$9.64
+0.34 (3.66%)Did MTEX Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Mannatech is one of their latest high-conviction picks.
MTEX has shown a year-to-date change of -28.2% and a 1-year change of -12.4%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MTEX. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MTEX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to Mannatech based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Mannatech, Incorporated has a market capitalization of $18.32M with a P/E ratio of 8.0x. The company generates $110.41M in trailing twelve-month revenue with a -1.5% profit margin.
Revenue growth is -8.1% quarter-over-quarter, while maintaining an operating margin of +6.9% and return on equity of -19.5%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops and distributes health and wellness products.
Mannatech operates primarily through a multilevel marketing model, generating revenue by marketing and distributing nutritional supplements, skincare products, and weight-management solutions. The company leverages direct sales channels, allowing it to reach a broad international customer base and capitalize on the growing demand for personalized health products.
Headquartered in Flower Mound, Texas, Mannatech focuses on glyconutrient products that enhance cellular communication, positioning itself strongly within the nutraceutical industry. The company's commitment to innovative research and development supports its role in the global trend towards natural and holistic health solutions.
Consumer Defensive
Food Distribution
189
Mr. Landen Granvel Fredrick
United States
1999
Mannatech, Inc. (NASDAQ: MTEX) reported its third-quarter financial results for 2025, highlighting its focus on health and wellness. Further details on performance were not provided.
Mannatech's Q3 2025 financial results will provide insights into its performance and growth potential, impacting investor sentiment and stock valuation.
Mannatech, Inc. reported Q2 2025 net sales of $25.7 million, a 7.4% decrease from $27.7 million in Q2 2024.
Mannatech's 7.4% decline in net sales signals potential issues in demand or competition, impacting investor confidence and future growth prospects.
Mannatech, Inc. (NASDAQ: MTEX) has promoted Peter Griscom to Chief Operating Officer, effective July 1, 2025. He has over 10 years in direct selling and consumer goods experience.
Peter Griscom's promotion to COO may enhance operational efficiency and strategic direction at Mannatech, potentially improving financial performance and investor confidence.
Mannatech, Inc. announced that all proposals were approved by shareholders at its annual meeting on June 3, 2025, chaired by J. Stanley Fredrick. CFO James Clavijo addressed attendees.
Shareholder approval of all proposals can indicate strong support for the company's strategy and governance, potentially boosting investor confidence and affecting stock performance positively.
Mannatech, Inc. reported Q1 2025 net sales of $26.6 million, down 9.6% from $29.4 million in Q1 2024.
Mannatech's 9.6% decline in net sales signals potential revenue challenges, impacting profitability and investor confidence in the companyโs financial health.
Mannatech, Inc. (NASDAQ: MTEX) reported Q4 2024 net sales of $29.0 million, down 11.3% from $32.7 million in Q4 2023. Sales declined 9.2% on a constant dollar basis.
Mannatech's fourth quarter sales decline signals potential struggles in revenue growth, which may impact stock performance and investor confidence in future profitability.
Analyst forecasts for Mannatech, Incorporated (MTEX) are not currently available. The stock is trading at $9.64.
Analyst ratings for MTEX are not currently available. The stock is currently trading at $9.64. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for MTEX are not currently available. The stock is trading at $9.64.
Mannatech operates primarily through a multilevel marketing model, generating revenue by marketing and distributing nutritional supplements, skincare products, and weight-management solutions. The company leverages direct sales channels, allowing it to reach a broad international customer base and capitalize on the growing demand for personalized health products.
Price targets from Wall Street analysts for MTEX are not currently available. The stock is trading at $9.64.
Price targets from Wall Street analysts for MTEX are not currently available. The stock is trading at $9.64.
Analyst ratings for MTEX are not currently available. The stock is trading at $9.64.
Stock price projections, including those for Mannatech, Incorporated, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.